Krawtschuk Christopher 4
4 · bluebird bio, Inc. · Filed Dec 5, 2022
Insider Transaction Report
Form 4
Krawtschuk Christopher
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-01+50,000→ 50,000 total - Award
Stock Options (Right to buy)
2022-12-01+100,000→ 100,000 totalExercise: $7.61Exp: 2032-12-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 12/1/2023, 25% on 12/1/2024, 25% on 12/1/2025, and 25% on 12/1/2026.
- [F2]The stock option vests over a four-year period at the rate of 25% on 12/1/2023 and then in 36 equal monthly installments thereafter.